| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/30/2011 | CN101991747A Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis |
| 03/30/2011 | CN101991745A Chinese medicine composition for liver dysfunction and preparation method thereof |
| 03/30/2011 | CN101991737A Stomach medicine |
| 03/30/2011 | CN101991733A Application of agastache rugosus extract in preparing drug for lowering viscera sensitivity |
| 03/30/2011 | CN101991720A Jiechangning target-oriented drug delivery preparation and application thereof |
| 03/30/2011 | CN101991719A Lotion for treating infantile diarrhea |
| 03/30/2011 | CN101991711A Traditional Chinese medicine composition for viscera fire syndrome and preparation method thereof |
| 03/30/2011 | CN101991699A Traditional Chinese medicine for treating stomach fire toothache and aphthous stomatitis |
| 03/30/2011 | CN101991698A Medicinal food product for dissipating and removing stone and preparation method |
| 03/30/2011 | CN101991697A Preparation with functions of clearing away heat and reducing fire and preparation method thereof |
| 03/30/2011 | CN101991685A Traditional Chinese medicine for treating chronic hepatitis |
| 03/30/2011 | CN101991675A Tea bag for moistening intestine and expelling toxin |
| 03/30/2011 | CN101991674A Composition of safflower oil and hawthorn extracts and application thereof |
| 03/30/2011 | CN101991667A Traditional Chinese medicinal composition for treating coccidiosis and enteritis |
| 03/30/2011 | CN101991659A Preparation with functions of clearing heat and releasing toxin and preparation method |
| 03/30/2011 | CN101991657A Traditional Chinese medicine for treating acute gastroenteritis |
| 03/30/2011 | CN101991656A Medicament for treating mouth disease |
| 03/30/2011 | CN101991655A Traditional Chinese medicinal embrocation for treating aphtha |
| 03/30/2011 | CN101991652A Traditional Chinese medicine for treating liver cirrhosis |
| 03/30/2011 | CN101991650A Cassia seed and fructus cannabis capsules |
| 03/30/2011 | CN101991646A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/30/2011 | CN101991644A Composition of safflower oil and salvia extracts and application thereof |
| 03/30/2011 | CN101991642A Walnut ointment preparation method |
| 03/30/2011 | CN101991633A Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof |
| 03/30/2011 | CN101991631A Traditional Chinese medicine composition used for logged middle burner and preparation method thereof |
| 03/30/2011 | CN101991620A Medicament prepared from okra extractive and application thereof |
| 03/30/2011 | CN101991615A Method for producing ganoderma spore by breaking wall |
| 03/30/2011 | CN101991613A Diarrhea and dysentery arresting medicine and preparation method thereof |
| 03/30/2011 | CN101991610A method for structuring hepatitis E infection model |
| 03/30/2011 | CN101991609A Efficient three-in-one royal jelly soft capsule |
| 03/30/2011 | CN101991604A Forest frog oil capsules and preparation method |
| 03/30/2011 | CN101991598A Use of sulfated fucan in preparing medicines for treatment of gastrointestinal diseases |
| 03/30/2011 | CN101991591A Compound apramycin sulfate injection and preparation method thereof |
| 03/30/2011 | CN101991587A Compound sulfadiazine injection and preparation method thereof |
| 03/30/2011 | CN101991576A Use of xanthine compound and pharmaceutical composition thereof |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101991563A Tooth sensitivity treatment compositions |
| 03/30/2011 | CN101991562A Tooth sensitivity treatment compositions |
| 03/30/2011 | CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof |
| 03/30/2011 | CN101991543A Omeprazole enteric dried suspension agent and preparation method thereof |
| 03/30/2011 | CN101991542A Lansoprazole enteric dry suspension and preparation method thereof |
| 03/30/2011 | CN101991539A Silybin nano crystal preparation and preparation method thereof |
| 03/30/2011 | CN101991532A Self-microemulsion composition, microemulsion and preparation methods thereof |
| 03/30/2011 | CN101991130A Method for preparing dark brown sugar flour |
| 03/30/2011 | CN101991107A method for preparing sesame honey paste |
| 03/30/2011 | CN101991106A Liver nourishing tea and preparation method thereof |
| 03/30/2011 | CN101712649B Lotus leaf extract, monomer component and application thereof |
| 03/30/2011 | CN101700357B Traditional Chinese medicine for treating gastric ulcer |
| 03/30/2011 | CN101632741B Detection method for traditional Chinese formulation for clearing heat, detoxifying, promoting digestion and nourishing stomach |
| 03/30/2011 | CN101612383B Medicine for treating stomach cancer and esophagus cancer and preparation method thereof |
| 03/30/2011 | CN101612230B Medicine wine for tonifying the kidney and tonifying Yang |
| 03/30/2011 | CN101524476B Gastrosia treating medicine and preparation method thereof |
| 03/30/2011 | CN101480453B Hepatinica for egg-shaped pompano |
| 03/30/2011 | CN101396379B Fermentation of Hericium caput-medusae |
| 03/30/2011 | CN101390851B Double-cyclitol medicine composition containing surfactant and preparation method thereof |
| 03/30/2011 | CN101361946B Traditional Chinese medicine combination for treating hepatitis B |
| 03/30/2011 | CN101357215B Medicine combination for treating viral hepatitis and quality control method thereof |
| 03/30/2011 | CN101352488B Medicament composition for damp-heat type icterohepatitis and preparation method thereof |
| 03/30/2011 | CN101314752B Cortex acanthopanacis mild health care yellow rice wine and preparation thereof |
| 03/30/2011 | CN101310761B Composition for warming the middle energizer and regulating the stomach, preparation method and quality control method thereof |
| 03/30/2011 | CN101259269B Freeze-drying hepatitis A varicella attenuation combined vaccine and producing method thereof |
| 03/30/2011 | CN101229275B Compounds used for tonifying the kidney, nourishing the liver and preparing method thereof |
| 03/30/2011 | CN101133049B Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 03/30/2011 | CN101085045B Traditional Chinese medicine preparation for treating stomatitis |
| 03/30/2011 | CN101073351B Memory-enhancing tea with brain-invigorating and vision-improving functions |
| 03/30/2011 | CN101053655B Preparing method for traditional Chinese medicine coptidis rhizome stir-fried with ginger juice |
| 03/30/2011 | CN101032323B Functionality foods including ginger oil resin |
| 03/29/2011 | US7915423 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 03/29/2011 | US7915413 Compounds |
| 03/29/2011 | US7915411 Anti-viral compounds |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915258 Substituted 2,5-dihydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | US7915232 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| 03/29/2011 | US7915228 Derivatives of asimadoline with covalently bonded acids |
| 03/29/2011 | US7914817 Treatment of inflammatory bowel disease |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2631880C Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 03/29/2011 | CA2494892C Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2436764C Rehydration composition |
| 03/29/2011 | CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/29/2011 | CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | WO2011035142A1 Use of opioid receptor antagonist for gastrointestinal tract disorders |
| 03/24/2011 | WO2011035005A2 Compositions and methods for reducing the risk of agent-induced liver toxicity |
| 03/24/2011 | WO2011034915A1 Compositions and methods for treating disorders of gastrointestinal motility |
| 03/24/2011 | WO2011034659A2 Advantageous mu-opiate receptor peptide compounds |
| 03/24/2011 | WO2011034362A9 Composition containing saururus chinensis extract or sauchinone as an active ingredient, for preventing and treating diseases caused by the overexpression of lxr-α |